Brian Bosworth, M.D.

Gastroenterology

Publications

BIBLIOGRAPHY

Baugart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi R, Wiedmann M, McDonough P, Kim S, Berg D, Schukken Y, Scherl E, Simpson K. Culture independent analysis of ileal mucosal reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME Journal, 2007 0; 1-16

Bosworth, BP, Sanders A, Maltz CM. Common Variable Immunodeficiency masquerading as Crohn’s ileo-colitis. Inflamm Bowel Dis. 2006 Feb;12(2):151-2.

Bosworth B, Weine D, Lodhavia P, Kim M, Scherl E. Crohn’s and Colitis at the crossroads Part 1: Impact of new strategies on old therapies – focus on 5-ASA Responders. Gastroenterology and Endoscopy News 2004: Vol 2; 41-5.

Bosworth BP, Landzberg BR. “Neurologic manifestations of gastrointestinal disease” in Neurobiology of Disease Gilman S ed. Elsevier Inc 2007; 689-702

Scherl EJ, Weine DM, Bosworth B, Green PH. Medical Therapy of Gastroduodenal Crohn’s Disease. In: Lichtenstein GR, ed. Inflammatory Bowel Disease: The complete guide to medical management. Slack, Inc. (in press).

L.   ABSTRACTS

Nash G; Krikhely A; Pieracci F; Milsom J; Trencheva K; Sonoda T; Bosworth B; Lee S. Minimally Invasive Management of Iatrogenic Colon Perforation. Gastrointest Endoscopy 2007 AB M1479

Bramlage M; Mendelsohn R; Makhoul Y; Scherl E; Yantiss R; Bosworth B Does the Degree Endoscopic Severity in Patients with Crohn's Disease Correlate with Pathologic Findings on Mucosal Biopsy Specimens. Gastroenterol 2007 AB T1412

Baugart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi R, Wiedmann M, McDonough P, Kim S, Berg D, Schukken Y, Scherl E, Simpson K Molecular Analysis of Mucosa-Associated Bacterial Diversity in Crohn’s Ileitis Gastroenterol 2007 AB W1515

Scherl EJ, Bosworth BP. Rifaximin in the Treatment of Refractory Solitary Rectal Ulcer. Am J Gastroenterol 2006 101(9)

Poppers, DM, Bosworth BP, Weine D, Ni Q, Scherl ES. Serologic Markers in IBD: pANCA Decreases Quantitatively with Improved Disease Activity. Gastroenterology 2006: 130(4)s2, AB S1376

Pochapin M, Schnoll-Sussman FH. Role of Endoscopic Ultrasound in the Evaluation of Gastric Fold Thickening Identified on Abdominal CT Scan. Am J Gastroenterol 2005: 100(9) AB93

Bosworth BP, Pochapin M, Schnoll-Sussman FH. Role of Endoscopic Ultrasound in the Evaluation of Gastric Fold Thickening Identified on Abdominal CT Scan. Am J Gastroenterol 2005: 100(9) AB93

Bosworth BP, Scherl E. A novel nonabsorbable antibiotic (rifaximin) in the treatment of moderate to severe Crohn’s disease. Gastroenterology 2005: 128(4)s2 AB W1013.

Bosworth BP, Schnoll-Sussman FH. How good are we doing at educating our Fellows in PillCam Endoscopy? International Conference on Capsule Endoscopy: Miami, FL 2005.

Bosworth BP, Schnoll-Sussman FH, Scherl EJ. Video Capsule Endoscopy diagnosis of oxaliplatin-induced enteritis in a patient with x-ray negative Crohn’s disease. Am J Gastroenterol 2004: 99 s10; AB 576

Bosworth BP, Schnoll-Sussman FH. Capsule Endoscopy in the diagnosis of hamartomatous polyposis. International Conference on Capsule Endoscopy: Miami, FL 2004.

David J, Bosworth B, Carlson M. Colonoscopy as tolerated with oral midazolam for colorectal cancer screening in average risk patients – the CATOM study. Gastrointest Endosc 2003; 57(5): AB236

Shah V, Stevens P, Milkes D, Onime G, Bosworth B, Factor S, Garcia-Carrasquillo R, Lightdale C. Validation of the Rockall and Baylor bleeding team scores in patients with upper gastrointestinal bleeding. Gastrointest Endosc 1999; 49:AB169.

Itescu S, Weinberg A, Burke E, Bosworth B, Smith C, Suciu-Foca N, Galantowicz M, Schulman L. Risk factors for early onset obliterative bronchiolitis after lung transplantation: influence of donor HLA-DR4 type. J Heart and Lung Transplantation 1997; 16:113.

Itescu S, Burke E, Weinberg A, Levin H, Bosworth B, Spanier S, Rose E, Suciu-Foca N, Michler R, Oz M. B-cell hyperactivity in recipients of left ventricular assist devices (LVAD): Association of HLA-DR3 with anti-HLA antibodies. J Heart and Lung Transplantation 1997; 16:258.

Itescu S, Weinberg A, Burke E, Levin H, Bosworth B, Spanier S, Rose E, Suciu-Foca N, Oz M, Michler R. B-cell hyperactivity in recipients of left ventricular assist devices: Association of HLA-DR3 with anti-HLA antibodies and adverse outcome post-cardiac transplantation. Circulation 1996; 94:1706.

Itescu S, Weinberg A, Burke E, Bosworth B, Rose E, Reed E, Suciu-Foca N, Michler R. “Certain HLA-DR types in the donor heart associated with accelerated coronary artery disease in transplant recipients.” The International Society for Heart and Lung Transplantation: New York, NY; 1996.

Back to topBack To Top